72
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C – a cross-sectional study

, , , , , , , & show all
Pages 55-62 | Published online: 21 Jan 2014

References

  • National Institute of Allergy and Infectious DiseasesHepatitis C2011 Available from: http://www.niaid.nih.gov/topics/hepatitis/hepatitisc/Pages/Default.aspxAccessed December 12, 2013
  • ChristensenPBClausenMRKrarupHLaursenALSchlichtingPWeisNTreatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection – Danish national guidelines 2011Dan Med J2012596C446522677253
  • FongIWEmerging relations between infectious diseases and coronary artery disease and atherosclerosisCMAJ20001631495610920732
  • RoedTLebechAMKjaerAWeisNHepatitis C virus infection and risk of coronary artery disease: a systematic review of the literatureClin Physiol Funct Imaging201232642143023031062
  • ButtAAXiaoqiangWBudoffMLeafDKullerLHJusticeACHepatitis C virus infection and the risk of coronary diseaseClin Infect Dis200949222523219508169
  • ButtAAKhanUAMcGinnisKASkandersonMKent KwohCCo-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veteransJ Viral Hepat2007141289089618070293
  • BoddiMAbbateRChelliniBHepatitis C virus RNA localization in human carotid plaquesJ Clin Virol2010471727519896417
  • AlbertiKGEckelRHGrundySMHarmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of ObesityCirculation2009120161640164519805654
  • HanounehIAFeldsteinAELopezRClinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infectionClin Gastroenterol Hepatol20086558458918455698
  • GrigorescuMRaduCCrisanDMetabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis CJ Gastrointestin Liver Dis200817214715418568135
  • HuangJFChuangWLYuMLHepatitis C virus infection and metabolic syndrome – a community-based study in an endemic area of TaiwanKaohsiung J Med Sci200925629930519560994
  • ShaheenMEcheverryDObladMGMontoyaMITeklehaimanotSAkhtarAJHepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III]Diabetes Res Clin Pract200775332032616919355
  • LorenzMWMarkusHSBotsMLRosvallMSitzerMPrediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysisCirculation2007115445946717242284
  • IshizakaNIshizakaYTakahashiEAssociation between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickeningLancet2002359930113313511809259
  • KiechlSEggerGMayrMChronic infections and the risk of carotid atherosclerosis: prospective results from a large population studyCirculation200110381064107011222467
  • O’MalleyTLudlamCARiemermsaRAFoxKAEarly increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromesEur Heart J200122141226123411440495
  • MulvihillNTFoleyJBMurphyRCreanPWalshMEvidence of prolonged inflammation in unstable angina and non-Q wave myocardial infarctionJ Am Coll Cardiol20003641210121611028472
  • TossHLindahlBSiegbahnAWallentinLPrognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery DiseaseCirculation19979612420442109416883
  • RidkerPMHennekensCHBuringJERifaiNC-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in womenN Engl J Med20003421283684310733371
  • RidkerPMHennekensCHRoitman-JohnsonBStampferMJAllenJPlasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy menLancet1998351909688929439492
  • HwangSJBallantyneCMSharrettARCirculating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) studyCirculation19979612421942259416885
  • BlankenbergSRupprechtHJBickelCCirculating cell adhesion molecules and death in patients with coronary artery diseaseCirculation2001104121336134211560847
  • Juhan-VagueIPykeSDAlessiMCJespersenJHaverkateFThompsonSGFibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and DisabilitiesCirculation1996949205720638901651
  • ColletJPMontalescotGVicautEAcute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortalityCirculation2003108439139412860898
  • ZhangRBrennanMLFuXAssociation between myeloperoxidase levels and risk of coronary artery diseaseJAMA2001286172136214211694155
  • TimmsPMMannanNHitmanGACirculating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?QJM2002951278779612454321
  • BrennanMLPennMSVan LenteFPrognostic value of myeloperoxidase in patients with chest painN Engl J Med2003349171595160414573731
  • HlatkyMAAshleyEQuertermousTMatrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery diseaseAm Heart J200715461043105118035073
  • BaldusSHeeschenCMeinertzTMyeloperoxidase serum levels predict risk in patients with acute coronary syndromesCirculation2003108121440144512952835
  • KirkwoodBRSterneJACEssential Medical StatisticsOxfordBlackwell Science Ltd2003
  • SchnohrPJensenGNyboeJEybjaerg HansenAThe Copenhagen City Heart Study. A prospective cardiovascular population study of 20,000 men and womenUgeskr Laeger19771393219211923 Danish906112
  • FordESPrevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the USDiabetes Care200528112745274916249550
  • SteinJHKorcarzCEHurstRTUse of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular MedicineJ Am Soc Echocardiogr200821293111 quiz 189–19018261694
  • LorenzMWvon KeglerSSteinmetzHMarkusHSSitzerMCarotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS)Stroke2006371879216339465
  • RidkerPMDanielsonEFonsecaFARosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinN Engl J Med2008359212195220718997196
  • van der MeerIMBotsMLHofmanAdel SolAIvan der KuipDAWittemanJCPredictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam StudyCirculation200410991089109414993130
  • Guzman-FulgencioMBerenguerJde CastroIFSustained virological response to interferon-alpha plus ribavirin decreases inflammation and endothelial dysfunction markers in HIV/HCV co-infected patientsJ Antimicrob Chemother201166364564921393232
  • BerzigottiABonfiglioliAMuscariAReduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosisLiver Int200525233133615780058
  • HowellWLManionWCThe low incidence of myocardial infarction in patients with portal cirrhosis of the liver: A review of 639 cases of cirrhosis of the liver from 17,731 autopsiesAm Heart J19606034134414403495
  • PencinaMJD’AgostinoRBSrLarsonMGMassaroJMVasanRSPredicting the 30-year risk of cardiovascular disease: the Framingham Heart StudyCirculation2009119243078308419506114
  • OmlandLHJepsenPKrarupHIncreased mortality among persons infected with hepatitis C virusClin Gastroenterol Hepatol201191717820888437
  • HuiJMSudAFarrellGCInsulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]Gastroenterology200312561695170414724822
  • Romero-GomezMDel Mar ViloriaMAndradeRJInsulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patientsGastroenterology2005128363664115765399
  • BiloraFRinaldiRBocciolettiVPetrobelliFGirolamiAChronic viral hepatitis: a prospective factor against atherosclerosis. A study with echo-color Doppler of the carotid and femoral arteries and the abdominal aortaGastroenterol Clin Biol200226111001100412483132
  • CoreyKEKaneEMunroeCBarlowLLZhengHChungRTHepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-upHepatology20095041030103719787818